Skip to main content
Journal cover image

Superior vena cava syndrome during veno-venous extracorporeal membrane oxygenation for COVID-19.

Publication ,  Journal Article
Kopanczyk, R; Al-Qudsi, OH; Ganapathi, AM; Potere, BR; Pagel, PS
Published in: Perfusion
September 2021

Superior vena cava (SVC) syndrome is typically associated with malignant tumors obstructing the SVC, but as many as 40% of cases have other etiologies. SVC obstruction was previously described during veno-venous extracorporeal membrane oxygenation therapy (VV ECMO) in children. In this report, we describe a woman with adult respiratory distress syndrome resulting from infection with coronavirus-19 who developed SVC syndrome during VV ECMO. A dual-lumen ECMO cannula was inserted in the right internal jugular vein, but insufficient ECMO circuit flow, upper body edema, and signs of hypovolemic shock were observed. This clinical picture resolved when the right internal jugular vein was decannulated in favor of bilateral femoral venous cannulae. Our report demonstrates that timely recognition of clinical signs and symptoms led to the appropriate diagnosis of an uncommon ECMO complication.

Duke Scholars

Published In

Perfusion

DOI

EISSN

1477-111X

Publication Date

September 2021

Volume

36

Issue

6

Start / End Page

630 / 633

Location

England

Related Subject Headings

  • Vena Cava, Superior
  • Superior Vena Cava Syndrome
  • SARS-CoV-2
  • Humans
  • Female
  • Extracorporeal Membrane Oxygenation
  • COVID-19
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kopanczyk, R., Al-Qudsi, O. H., Ganapathi, A. M., Potere, B. R., & Pagel, P. S. (2021). Superior vena cava syndrome during veno-venous extracorporeal membrane oxygenation for COVID-19. Perfusion, 36(6), 630–633. https://doi.org/10.1177/0267659120987973
Kopanczyk, Rafal, Omar H. Al-Qudsi, Asvin M. Ganapathi, Bethany R. Potere, and Paul S. Pagel. “Superior vena cava syndrome during veno-venous extracorporeal membrane oxygenation for COVID-19.Perfusion 36, no. 6 (September 2021): 630–33. https://doi.org/10.1177/0267659120987973.
Kopanczyk R, Al-Qudsi OH, Ganapathi AM, Potere BR, Pagel PS. Superior vena cava syndrome during veno-venous extracorporeal membrane oxygenation for COVID-19. Perfusion. 2021 Sep;36(6):630–3.
Kopanczyk, Rafal, et al. “Superior vena cava syndrome during veno-venous extracorporeal membrane oxygenation for COVID-19.Perfusion, vol. 36, no. 6, Sept. 2021, pp. 630–33. Pubmed, doi:10.1177/0267659120987973.
Kopanczyk R, Al-Qudsi OH, Ganapathi AM, Potere BR, Pagel PS. Superior vena cava syndrome during veno-venous extracorporeal membrane oxygenation for COVID-19. Perfusion. 2021 Sep;36(6):630–633.
Journal cover image

Published In

Perfusion

DOI

EISSN

1477-111X

Publication Date

September 2021

Volume

36

Issue

6

Start / End Page

630 / 633

Location

England

Related Subject Headings

  • Vena Cava, Superior
  • Superior Vena Cava Syndrome
  • SARS-CoV-2
  • Humans
  • Female
  • Extracorporeal Membrane Oxygenation
  • COVID-19
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology